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610a Wednesday, March 4, 2009for association processes and nanoclustering, which has also been observed in
in vivo studies. No significant changes of the localization between GDP- and
GTP-loaded N-Ras could be detected. Conversely, the non-biological dual-
hexadecylated N-Ras exhibits a time-independent incorporation into the bulk
liquid-disordered phase to maintain high conformational entropy of its lipid
chains.
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Extensive experimental studies have validated the necessity of the anionic
lipid phosphatidic acid (PA) and/or cholesterol (CHOL) for functional nico-
tinic acetylcholine receptor (nAChR). At molecular lever, however, it is still
unclear how PA and CHOL modulate the functionality of nAChR. We inves-
tigated the modulation mechanism through molecular dynamics (MD) simu-
lations of both open- and closed-channel a4b2 nAChR embedded into
a ternary lipid mixture of 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC),
1-palmitoyl-2-oleoyl phosphatidic acid (POPA), and cholesterol with
a POPC:POPA:CHOL ratio of 3:1:1. Unique interactions of POPA with the
closed- and open-channel nAChR were revealed in MD simulations. We iden-
tified several putative POPA binding sites, which were formed by the highly
conserved residues at the interfaces of the extracellular and transmembrane
domains or the intracellular and transmembrane domains of a4b2. Our MD
simulations also suggested that POPA might stabilize the open-channel struc-
ture through better hydrogen bonding and salt-bridging with its residues in the
open channel. The total numbers of hydrogen bonds and salt-bridges formed
between POPA and nAChR were 3 and 5 times more in the open-channel than
in the closed-channel, respectively. The salt-bridges lasted for nanoseconds in
the open channel but only ~100 ps in the closed-channel. The POPA mole-
cules that formed salt-bridges with nAChR showed higher order parameters
than the POPA in the bulk lipids, while the order parameters for lipids at
the lipid-protein interface were generally reduced. These results collectively
suggest that the interactions between POPA and nAChR may potentially
modulate the channel gating and preferentially enhance receptor function.
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The rates of enzymatic reactions involved in the blood clotting cascade are en-
hanced by several orders of magnitude upon binding of coagulation factors to
anionic regions of the cell membrane. This key process hinges on two special-
ized membrane-anchoring domains, the GLA domain and the C2 domain. We
have recently reported a membrane-bound model of the GLA domain. Here we
report the results of our simulations investigating membrane association and
insertion of the C2 domain, which exhibits a completely different behavior
from the GLA domain, both in terms of the overall architecture and its
Ca2þ-independent membrane binding.
Both crystalographically solved, open and closed forms of the C2 domain of
factor V were equilibrated over 50 ns in solution and inserted gradually (0.5
A˚/ns) into a pre-equilibrated DOPS bilayer. During the insertion, lateral tension
of 36 dyn/cm (calibrated based on several independent simulations of pure
DOPS bilayers) was applied to the membrane to prevent over-shrinking and
to allow its expansion upon C2 binding.
In contrast to the proposed implication of the two states, multiple transitions
between the open and closed states were observed in solution. During mem-
brane insertion, however, the open form closed near the surface of the mem-
brane with K23 and R43 residues establishing direct interaction with the mem-
brane. Subsequently, W26 in Loop1 was inserted into the DOPS tail region.
The results provide a membrane-bound model of the C2 domain and suggest
that, in contrast to the GLA domain, Ca2þ-independent, specific interactions
between protein side chains and the membrane, associated with backbone con-
formational changes of the inserted loops, are the primary forces catalyzing
membrane binding of the C2 domain.3148-Pos Board B195
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PTEN, phosphatase and tensin homologue deleted on chromosome 10, has been
identified as one of the most highly mutated or deleted tumor suppressors in-
volved in tumorigenesis, second only to p53. This enzyme works to regulate
the PI3K pathway by specifically dephosphorylating PI(3,4,5)P3 at the 3 posi-
tion of the inositol ring in order to control basal levels of the phosphoinositide,
which in turn controls the levels of phosphoAkt within the cell. We have pre-
viously shown that PTEN binds specifically to PI(4,5)P2, its product, which
causes a conformational change which is thought to allosterically activate the
protein. It has been recently discovered that Ceramide-1-Phosphate also plays
a role in the PI3K pathway, increasing the levels of phospoAkt within the cell
by some unknown mechanism. We have tested the ability of PTEN to interact
with model membranes containing Ceramide-1-Phosphate and undergo confor-
mational changes in its presence. Surprisingly, while PTEN does not interact
significantly with membranes containing POPC and Ceramide-1-Phosphate,
the interaction of PTEN with membranes containing PI(4,5)P2 decreases in
the presence of Ceramide-1-Phosphate. Additionally, the conformational
changes typically observed upon interaction of PTENwith membranes contain-
ing PI(4,5)P2 do not occur when Ceramide-1-Phosphate is added to the mem-
brane. These data suggest that Ceramide-1-Phosphate may affect the PI3K
pathway by preventing the interaction and subsequent activation of PTEN by
PI(4,5)P2.
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Bovine beta-lactoglobulin (b-LG) is a lipocalin protein found in mammalian
milk. In the native state, its secondary structure is dominated by beta-sheet,
though it has the propensity to form a-helices based on secondary structure
predictions. We have shown that b-LG can adopt a significant fraction of al-
pha-helical conformation upon mixing with synthetic phospholipid vesicles.
The thermodynamic and kinetic aspects of interaction between b-LG and lipid
vesicles have been previously studied. However, the function of b-LG is still
not clear. In this work, a leakage experiment has been conducted to analyze
the degree of leakage of small molecules through the lipid bilayer as enabled
by b-LG. Furthermore, the factor of membrane curvature for the interaction
has been investigated by varying the composition of vesicles by changing pro-
portion of PC, PG and PE. Finally, the role of cholesterol for the protein-lipid
interaction is studied to illustrate a potential function for b-LG in mammalian
species.
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Although the presence of cholesterol, the major neutral lipid component, is well
known in native surfactants (upto 10 % mass), its role in the surfactant remains
uncertain. The most recently FDA approved clinical surfactant contain choles-
terol, while two that have been used for 20 years have cholesterol carefully re-
moved. However, they are all successful in treating neonatal respiratory distress
syndrome (NRDS) resulting from a lack of surfactant. As a result the optimal
concentration of cholesterol, if any at all, remains debated. Here we present in-
dications for an optimal cholesterol concentration by presenting alterations to
the phase and morphology of Survanta, a clinically used bovine lung surfactant
extract, induced by both physiological and elevated concentrations of choles-
terol when the monolayer is in contact with surfactant in the subphase. We
find that low cholesterol concentrations (1-2 wt %) help to achieve a lower
surface tension by enhancing surfactant material adsorption to the interface.
However, increasing the cholesterol concentrations to higher values (z 20
wt%) significantly alters the normal surfactant isotherm. Alterations in a typical
signature plateau for Survanta at ~ 40 mN/m are noted suggesting a change in
the solid phase fraction of the film. Fluorescence microscopic imaging reveals
the coexistence of discrete monolayer along with ‘‘multilayer reservoir’’ adja-
cent to the air/water interface. Differences in the collapse structures of the
monolayer are also noted indicating an alteration in the mechanical properties
